Intratumoral injection of CXCL10 leads to reduced growth and impaired angiogenesis and metastasis in murine adenocarcinoma and studies have shown a synergistic effect against tumours through its immunomodulatory properties in murine models of glioma and melanoma [37–39]. This evidence concerns the gene CXCL10 and melanoma.